Litcius/Paper detail

BCL9/BCL9L promotes tumorigenicity through immune-dependent and independent mechanisms in triple negative breast cancer

X. Wang, Mei Feng, Tengfei Xiao, Baosen Guo, Danyang Liu, Chenglong Liu, Jinpeng Pei, Qiaofeng Liu, Yi Xiao, Rina Rosin‐Arbesfeld, Ying Shi, Yang Zhou, Mengxuan Yang, Yuxiong Feng, Yi‐Zhou Jiang, Zhimin Shao, Ker Yu, Di Zhu

2021Oncogene47 citationsDOI

Topics & Concepts

BiologyWnt signaling pathwayCancer researchCytotoxic T cellTriple-negative breast cancerTumor microenvironmentImmune systemCD8MetastasisImmunologySignal transductionCell biologyCancerBreast cancerBiochemistryGeneticsIn vitroImmunotherapy and Immune ResponsesPeptidase Inhibition and AnalysisCancer Immunotherapy and Biomarkers
BCL9/BCL9L promotes tumorigenicity through immune-dependent and independent mechanisms in triple negative breast cancer | Litcius